The White House on Feb. 5 launched TrumpRx, a direct-to-consumer website aimed at reducing prescription drug costs by linking patients to manufacturer discounts — but many listed drugs are available for less elsewhere. The site primarily targets uninsured patients or…
Pharmacy
Pfizer has received FDA priority review for a supplemental biologics license application to expand the indication of Hympavzi (marstacimab). The proposed label expansion would include patients with hemophilia A or B ages 6 and older with inhibitors and pediatric patients…
Ascension Illinois has launched a pharmacy assistance program aimed at expanding medication access for low-income, uninsured residents across Chicago and its suburbs. The initiative is part of a national partnership with Dispensary of Hope, a nonprofit organization that distributes free,…
GoodRx said it is powering discounted drug pricing on TrumpRx, a federal direct-to-consumer platform that launched Feb. 5 with prices for 40 high-cost brand-name drugs. TrumpRx.gov connects patients with manufacturer-set cash prices under most-favored-nation agreements. The platform does not process…
HHS will drop its 340B rebate model pilot program following two federal court rulings that blocked its implementation. The pilot, announced in August 2025, was challenged by the American Hospital Association, the Maine Hospital Association and four safety-net health systems,…
Advertisement
The White House launched TrumpRx.gov Feb. 5, a federal direct-to-consumer platform offering discounts on 40 high-cost prescription drugs. The site was first announced in September when the administration began negotiating most-favored-nation pricing agreements requiring drugmakers to match U.S. prices to…
Cost Plus Drugs founder Mark Cuban is not convinced the Federal Trade Commission’s settlement with Cigna’s Express Scripts is going to amount to very much. “My initial response to the FTC [and pharmacy benefit manager] settlements … meh. [G]reat intent.…
CVS Caremark identified four pipeline drugs that could reshape care delivery in 2026, with potential FDA approvals spanning weight management, diabetes, breast cancer and emergency allergy treatment. According to the company’s “Q1 Drugs to Watch Report,” the therapies reflect broader…
As therapies become more specialized and expensive, patients are relying on pharmacy teams for more than medication dispensing. Health systems are responding by integrating pharmacists more deeply into clinical care, particularly in specialty and oncology settings, where treatment complexity and…
The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. With the move, the FTC expects to lower out-of-pocket costs for drugs…